NKAIN3 inhibitors refer to a class of chemical compounds that specifically target and inhibit the function of the NKAIN3 protein. NKAIN3, or Na+/K+ transporting ATPase interacting protein 3, is a member of the NKAIN family of transmembrane proteins, which are involved in regulating the activity of the Na+/K+ ATPase pump. This pump plays a critical role in maintaining ion homeostasis by transporting sodium and potassium ions across the cell membrane, which is essential for various physiological processes. NKAIN3 is believed to interact with this pump, modulating its activity and influencing ion balance within cells. Inhibitors of NKAIN3 are designed to interfere with these regulatory interactions, potentially altering the activity of the Na+/K+ ATPase pump and the cellular processes dependent on it.
Structurally, NKAIN3 inhibitors can belong to a variety of chemical families, depending on their mode of interaction with the NKAIN3 protein. These inhibitors may be small molecules that fit into the binding sites of NKAIN3 or regions associated with its interaction with the Na+/K+ ATPase pump. By binding to NKAIN3, these inhibitors can modify the conformation or activity of the protein, leading to changes in ion transport dynamics. Understanding the specific binding mechanisms and structural characteristics of NKAIN3 inhibitors is essential for developing compounds with high specificity and efficacy in modulating the function of this protein. Moreover, research on NKAIN3 inhibitors offers insight into the broader role of the NKAIN family in cellular ion transport and signaling, providing valuable information on how these processes are regulated at the molecular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Ouabain is a well-known inhibitor of the Na+/K+-ATPase, indirectly affecting NKAIN3 by disrupting the activity of this enzyme, which is crucial for ion balance in cells. | ||||||
12β-Hydroxydigitoxin | 20830-75-5 | sc-213604 sc-213604A | 1 g 5 g | $143.00 $694.00 | ||
12β-Hydroxydigitoxin inhibits Na+/K+-ATPase, impacting ion transport and indirectly influencing NKAIN3-related processes. | ||||||
Bufalin | 465-21-4 | sc-200136 sc-200136A sc-200136B sc-200136C | 10 mg 25 mg 50 mg 100 mg | $99.00 $204.00 $341.00 $544.00 | 5 | |
Bufalin is a cardiac glycoside that inhibits Na+/K+-ATPase, indirectly affecting the functional pathways involving NKAIN3. | ||||||
Digitoxin | 71-63-6 | sc-207577 sc-207577A sc-207577B sc-207577C sc-207577D | 250 mg 500 mg 1 g 5 g 10 g | $112.00 $186.00 $319.00 $1102.00 $2040.00 | 2 | |
Digitoxin, another cardiac glycoside, inhibits Na+/K+-ATPase, potentially influencing NKAIN3 by altering cellular ion dynamics. | ||||||
Amiloride • HCl | 2016-88-8 | sc-3578 sc-3578A | 25 mg 100 mg | $22.00 $57.00 | 6 | |
Amiloride, a diuretic, indirectly influences NKAIN3 through its effects on ion channels and transporters, including Na+/K+-ATPase. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $109.00 | 3 | |
Spironolactone, a potassium-sparing diuretic, can indirectly affect NKAIN3 by influencing Na+/K+-ATPase activity. | ||||||
Triamterene | 396-01-0 | sc-213103A sc-213103 | 1 g 5 g | $22.00 $54.00 | ||
Triamterene, another potassium-sparing diuretic, indirectly influences NKAIN3 through its effects on Na+/K+-ATPase. | ||||||
Eplerenone | 107724-20-9 | sc-203943 sc-203943A | 10 mg 50 mg | $110.00 $624.00 | 4 | |
Eplerenone, a selective aldosterone receptor antagonist, indirectly affects NKAIN3 by modulating the effects of aldosterone on Na+/K+-ATPase. | ||||||